Charles Cherington 13D and 13G filings for Eterna Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-11 8:39 pm Purchase | 2025-06-09 | 13D | Eterna Therapeutics Inc. ERNA | Charles Cherington | 2,779,385 37.900% | 1,417,209 (+104.04%) | Filing |
| 2025-04-04 10:55 am Purchase | 2025-04-02 | 13D | Eterna Therapeutics Inc. ERNA | Charles Cherington | 1,362,176 32.800% | 252,697 (+22.78%) | Filing |
| 2025-03-05 5:55 pm Purchase | 2024-10-29 | 13D | Eterna Therapeutics Inc. ERNA | Charles Cherington | 1,109,479 32.380% | 1,028,644 (+1272.52%) | Filing |
| 2023-12-22 12:05 pm Unchanged | 2023-12-14 | 13D | Eterna Therapeutics Inc. ERNA | Charles Cherington | 80,835 19.990% | 0 (Unchanged) | Filing |
| 2023-09-07 5:26 pm Purchase | 2023-07-13 | 13D | Eterna Therapeutics Inc. ERNA | Charles Cherington | 80,835 19.990% | 43,000 (+113.65%) | Filing |
| 2022-12-14 4:30 pm Purchase | 2022-12-02 | 13D | Eterna Therapeutics Inc. ERNA | Charles Cherington | 37,835 11.050% | 37,835 (New Position) | Filing |